Ml. Casey et al., 17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-2 - CHROMOSOMAL ASSIGNMENT AND PROGESTIN REGULATION OF GENE-EXPRESSION IN HUMAN ENDOMETRIUM, The Journal of clinical investigation, 94(5), 1994, pp. 2135-2141
The cDNAs for two separate human 17 beta-hydroxysteroid dehydrogenases
(17 beta-HSD) have been isolated and sequenced. The well-studied huma
n placental cytosolic 17 beta-HSD (also referred to as estradiol dehyd
rogenase) preferentially catalyzes the reduction of estrone to estradi
ol-17 beta and the reduction of the C-20-ketone of progesterone to 20
alpha-dihydroprogesterone. This isoform of the enzyme has been referre
d to as 17 beta-HSD type 1 and localized to chromosome 17. A second 17
beta-HSD isoform (referred to as type 2) is localized in the endoplas
mic reticulum of human trophoblast and is characterized by the prefere
ntial oxidation of the C-17 beta-hydroxyl group of C-18- and C-19-ster
oids and the C-20 alpha-hydroxyl group of 20 alpha-dihydroprogesterone
. In this study, we determined the chromosomal localization of human 1
7 beta-HSD type 2, the expression of this gene in human endometrium, a
nd the tissue distribution of the mRNA. We found that the human 17 bet
a-HSD type 2 gene is localized on chromosome 16, 16q24. 17 beta-HSD ty
pe 2 mRNA (similar to 1.5 kb) was identified in human endometrial tiss
ues by Northern analysis of total RNA (10 mu g). The highest levels of
17 beta-HSD type 2 mRNA were found in endometrial tissues obtained du
ring the mid- to late secretory phase of the ovarian cycle (i.e., duri
ng the time of high plasma levels of progesterone). 17 beta-HSD type 2
mRNA levels were much greater in glandular epithelium than in the str
omal cells isolated from secretory phase endometrium. The levels of 17
beta-HSD type 2 mRNA in secretory phase endometrium were approximatel
y one-tenth that in villous trophoblast tissue from human placenta. We
did not detect 17 beta-HSD type 1 mRNA in endometrial tissue by North
ern analysis of total (10 mu g) RNA. These findings are consistent wit
h the view that the progestin-regulated 17 beta-HSD of the glandular e
pithelium of the human endometrium is primarily, if not exclusively, t
he product of the 17 beta-HSD type 2 gene. 17 beta-HSD type 2 mRNA was
present in human placenta, liver, and small intestine; much smaller a
mounts, barely detectable by Northern analysis of poly(A)(+) RNA, were
present in prostate, kidney, pancreas, and colon, but not in heart, b
rain, skeletal muscle, spleen, thymus, ovary, or testis.